aluable therapeutic target.

ACE2 and Ang1-7: Clinical Trials
ACE2 regulates RAS signaling by reducing Ang II/AT1 receptor signaling and by activating the ACE2/Ang1-7/Mas counterregulatory pathway. Thus far, only a few pilot clinical studies have been conducted using rhACE2 in acute respiratory distr